KMTS — KESTRA MEDICAL TECHNOLOGIES, LTD.
$30.61+2.48%
Last close: · regular session
Last 60 sessions
KMTS closed at $30.61 (+2.48%) on Oct 29, 2026. Active automatic shelf (S-3ASR, Apr 2026); dilution risk: low. Float: 26.7M shares. Latest SEC filing: 144 on Oct 29, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for KMTS in the TickerWise workspace.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
Company profile
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
- Exchange: NASDAQ
- Employees: 300
- Website: https://kestramedical.com
Latest SEC filings for KMTS
Latest KMTS news
- Kestra Medical Technologies to Participate in Upcoming Investor Conferences Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.